மலேசியன் மருந்து கட்டுப்பாடு அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
From US$84,000 to US$100: Malaysia a step closer to eliminating hepatitis C with new, affordable drug
channelnewsasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from channelnewsasia.com Daily Mail and Mail on Sunday newspapers.
290,480 vials of Sinovac bottled by Pharmaniaga to be used from today 11 May 2021 / 17:32 H. Pix for illustration purposes.
PUTRAJAYA: A total of 290,480 vials of the Covid-19 Sinovac vaccine bottled by Pharmaniaga Bhd (Pharmaniaga) will be used at vaccination centres (PPV) nationwide starting today, Health Minister Datuk Seri Dr Adham Baba said.
It is the first batch handed over by the company to the Health Ministry (MOH), he said.
“We are now in the second phase of the National Covid-19 Immunisation Program. As reported, we received 400,000 doses of Covid-19 Sinovac vaccine supply directly from Beijing, China.
“The remaining vials from the first batch will also be used at PPVs this month,“ he told a press conference after the handover ceremony of the (Sinovac) vaccine in Malaysia undertaken through the fill and finish process here.
KUALA LUMPUR: CGS-CIMB Equities Research has upgraded its recommendation for Duopharma Biotech to an add from hold and kept its target price at RM3.67, which is 25.2% above the last closing price of RM2.93.
It said on Tuesday Duopharma’s current valuations look attractive after its recent share price weakness.
“Our TP is based on a CY22F P/E of 28.8 times (+ two standard deviation from its five-year mean) where we take into account potential long-term earnings prospects from the development of vaccine manufacturing capabilities, which is a key rerating catalyst, ” it said.
Duopharma also proposed one-for-three bonus issue, which it thinks could improve liquidity for the stock.
Viruses are modified to prevent disease before they are used as vehicles to deliver the required genes in gene therapy. Pixnio
We previously talked about people using genes to treat diseases nowadays. We also talked about scientists using certain “vectors” like viruses to deliver the gene into my body. But these vectors are viruses, right? What is to stop these viruses from causing diseases in my body? The most common viruses used as vectors in gene therapy are lentiviruses – one of which is HIV (human immunodeficiency virus) – and adenoviruses, which cause the common cold.
In gene therapy, these virus vectors are disabled beforehand,
vimarsana © 2020. All Rights Reserved.